Non-enzymatic cyclic oxygenated metabolites of omega-3 polyunsaturated fatty acid: Bioactive drugs?

Biochimie

Volumn 120, Issue , 2016, Pages 56-61

  Roy, Jérôme ^a   Le Guennec, Jean Yves ^a   Galano, Jean Marie ^a   Thireau, Jérôme ^a   Bultel Poncé, Valérie ^a   Demion, Marie ^a   Oger, Camille ^a   Lee, Jetty Chung Yung ^b   Durand, Thierry ^a  

^a UNIV MONTPELLIER   (France)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Arrhythmia; Isoprostanes; Neuroprostanes; Omega 3 PUFA; Oxidative stress

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; NEUROPROSTANE; OMEGA 3 FATTY ACID; ARACHIDONIC ACID; ISOPROSTANE DERIVATIVE;

ANIMAL CELL; BIOLOGICAL ACTIVITY; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; HUMAN; METABOLITE; NONHUMAN; OXIDATIVE STRESS; REVIEW; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; ARACHIDONIC ACID; EICOSAPENTAENOIC ACID; HUMANS; ISOPROSTANES; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84951567973     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.06.010     Document Type: Review

References (50)

1. C. Ruxton Health benefits of omega-3 fatty acids Nurs. Stand. R. Coll. Nurs. G. B. 18 2004 1987 38 42 10.7748/ns2004.08.18.48.38.c3668
2. H.W. Gardner Oxygen radical chemistry of polyunsaturated fatty acids Free Radic. Biol. Med 7 1989 65 86
3. L.B. Becker New concepts in reactive oxygen species and cardiovascular reperfusion physiology Cardiovasc. Res 61 2004 461 470 10.1016/j.cardiores.2003.10.025
4. C. Vigor, J. Bertrand-Michel, E. Pinot, C. Oger, J. Vercauteren, P. Le Faouder, and et al. Non-enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids J. Chromatogr. B Anal. Technol. Biomed. Life. Sci 964 2014 65 78 10.1016/j.jchromb.2014.04.042
5. J.-M. Galano, Y.Y. Lee, T. Durand, and J.C.-Y. Lee Special issue on "analytical methods for oxidized biomolecules and antioxidants" the use of isoprostanoids as biomarkers of oxidative damage, and their role in human dietary intervention studies Free Radic. Res 49 2015 583 598 10.3109/10715762.2015.1007969
6. U. Jahn, J.-M. Galano, and T. Durand Beyond prostaglandins-chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids Angew. Chem. Int. Ed. Engl 47 2008 5894 5955 10.1002/anie.200705122
7. G.L. Milne, H. Yin, K.D. Hardy, S.S. Davies, and L.J. Roberts Isoprostane generation and function Chem. Rev 111 2011 5973 5996 10.1021/cr200160h
8. T. Durand, J.-L. Cracowski, and O. Berdeaux Isoprostanes, biomarkers of lipid peroxidation in humans. Part 1. Nomenclature and synthesis Pathol. Biol. (Paris) 53 2005 349 355 10.1016/j.patbio.2004.10.005
9. J.P. Fessel, N.A. Porter, K.P. Moore, J.R. Sheller, and L.J. Roberts Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension Proc. Natl. Acad. Sci. U. S. A. 99 2002 16713 16718 10.1073/pnas.252649099
10. H. Yin, E.S. Musiek, L. Gao, N.A. Porter, and J.D. Morrow Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo J. Biol. Chem 280 2005 26600 26611 10.1074/jbc.M503088200
11. W.-L. Song, J.A. Lawson, D. Reilly, J. Rokach, C.-T. Chang, B. Giasson, and et al. Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid J. Biol. Chem 283 2008 6 16 10.1074/jbc.M706124200
12. M.B. Kadiiska, B.C. Gladen, D.D. Baird, D. Germolec, L.B. Graham, C.E. Parker, and et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic. Biol. Med 38 2005 698 710 10.1016/j.freeradbiomed.2004.09.017
13. J.D. Morrow, J.A. Awad, H.J. Boss, I.A. Blair, and L.J. Roberts Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids Proc. Natl. Acad. Sci. U. S. A. 89 1992 10721 10725
14. L.J. Roberts, and G.L. Milne Isoprostanes J. Lipid Res 50 Suppl 2009 S219 S223 10.1194/jlr.R800037-JLR200
15. L.J. Janssen Isoprostanes: an overview and putative roles in pulmonary pathophysiology Am. J. Physiol. Lung Cell. Mol. Physiol 280 2001 L1067 L1082
16. C.A. Opere, K. Ford, M. Zhao, and S.E. Ohia Regulation of neurotransmitter release from ocular tissues by isoprostanes Methods Find. Exp. Clin. Pharmacol 30 2008 697 701 10.1358/mf.2008.30.9.1303610
17. L.J. Roberts, and J.D. Morrow The generation and actions of isoprostanes Biochim. Biophys. Acta 1345 1997 121 135
18. J.-M. Galano, E. Mas, A. Barden, T.A. Mori, C. Signorini, C. De Felice, and et al. Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans Prostagl. Other Lipid Mediat 107 2013 95 102 10.1016/j.prostaglandins.2013.04.003
19. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat. Rev. Immunol 8 2008 349 361 10.1038/nri2294
20. C.N. Serhan, R. Yang, K. Martinod, K. Kasuga, P.S. Pillai, T.F. Porter, and et al. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions J. Exp. Med 206 2009 15 23 10.1084/jem.20081880
21. L. Minghetti, R. Salvi, M. Lavinia Salvatori, M.A. Ajmone-Cat, C. De Nuccio, S. Visentin, and et al. Nonenzymatic oxygenated metabolites of α-linolenic acid B1- and L1-phytoprostanes protect immature neurons from oxidant injury and promote differentiation of oligodendrocyte progenitors through PPAR-γ activation Free Radic. Biol. Med 73 2014 41 50 10.1016/j.freeradbiomed.2014.04.025
22. S. Sethi, A.Y. Eastman, and J.W. Eaton Inhibition of phagocyte-endothelium interactions by oxidized fatty acids: a natural anti-inflammatory mechanism? J. Lab. Clin. Med 128 1996 27 38
23. A. Mishra, A. Chaudhary, and S. Sethi Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway Arterioscler. Thromb. Vasc. Biol 24 2004 1621 1627 10.1161/01.ATV.0000137191.02577.86
24. Y. Araki, M. Matsumiya, T. Matsuura, M. Oishi, M. Kaibori, T. Okumura, and et al. Peroxidation of n-3 polyunsaturated fatty acids inhibits the induction of iNOS gene expression in proinflammatory cytokine-stimulated hepatocytes J. Nutr. Metab 2011 2011 374542 10.1155/2011/374542
25. S. Judé, S. Bedut, S. Roger, M. Pinault, P. Champeroux, E. White, and et al. Peroxidation of docosahexaenoic acid is responsible for its effects on I TO and I SS in rat ventricular myocytes Br. J. Pharmacol 139 2003 816 822 10.1038/sj.bjp.0705308
26. M. Pan, A.I. Cederbaum, Y.-L. Zhang, H.N. Ginsberg, K.J. Williams, and E.A. Fisher Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production J. Clin. Invest 113 2004 1277 1287 10.1172/JCI19197
27. C. Cipollina, S.R. Salvatore, M.F. Muldoon, B.A. Freeman, and F.J. Schopfer Generation and dietary modulation of anti-inflammatory electrophilic omega-3 fatty acid derivatives PloS One 9 2014 e94836 10.1371/journal.pone.0094836
28. T. Itoh, L. Fairall, K. Amin, Y. Inaba, A. Szanto, B.L. Balint, and et al. Structural basis for the activation of PPARgamma by oxidized fatty acids Nat. Struct. Mol. Biol 15 2008 924 931
29. E.J. Anderson, K. Thayne, M. Harris, K. Carraway, and S.R. Shaikh Aldehyde stress and up-regulation of Nrf2-mediated antioxidant systems accompany functional adaptations in cardiac mitochondria from mice fed n-3 polyunsaturated fatty acids Biochem. J. 441 2012 359 366 10.1042/BJ20110626
30. D.F. Taber, R.S. Hoerrner, R.J. Herr, D.M. Gleave, K. Kanai, R. Pina, and et al. The diazo ketone approach to the isoprostanes Chem. Phys. Lipids 128 2004 57 67 10.1016/j.chemphyslip.2003.09.010
31. T. Durand, A. Guy, O. Henry, A. Roland, S. Bernad, S. El Fangour, and et al. Total syntheses of iso-, neuro- and phytoprostanes: new insight in lipid chemistry Chem. Phys. Lipids 128 2004 15 33 10.1016/j.chemphyslip.2003.10.008
32. G. Zanoni, E.M. Brunoldi, A. Porta, and G. Vidari Asymmetric synthesis of 14-A4t-neuroprostane: hunting for a suitable biomarker for neurodegenerative diseases J. Org. Chem 72 2007 9698 9703 10.1021/jo701719f
33. L. Gao, H. Yin, G.L. Milne, N.A. Porter, and J.D. Morrow Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid J. Biol. Chem 281 2006 14092 14099 10.1074/jbc.M601035200
34. L.J. Roberts, T.J. Montine, W.R. Markesbery, A.R. Tapper, P. Hardy, S. Chemtob, and et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid J. Biol. Chem 273 1998 13605 13612
35. D. Praticò, E.M. Smyth, F. Violi, and G.A. FitzGerald Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms J. Biol. Chem 271 1996 14916 14924
36. J.D. Brooks, E.S. Musiek, T.R. Koestner, J.N. Stankowski, J.R. Howard, E.M. Brunoldi, and et al. The fatty acid oxidation product 15-A3t-isoprostane is a potent inhibitor of NFκB transcription and macrophage transformation J. Neurochem 119 2011 604 616 10.1111/j.1471-4159.2011.07422.x
37. L. Gao, J. Wang, K.R. Sekhar, H. Yin, N.F. Yared, S.N. Schneider, and et al. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3 J. Biol. Chem 282 2007 2529 2537 10.1074/jbc.M607622200
38. E.S. Musiek, J.D. Brooks, M. Joo, E. Brunoldi, A. Porta, G. Zanoni, and et al. Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid J. Biol. Chem 283 2008 19927 19935 10.1074/jbc.M803625200
39. J. Jamil, P. Bankhele, A. Salvi, J.E. Manninx, C. Oger, J.M. Galano, T. Durand, Y.F. Njie-Mbye, S.E. Ohia, and C.A. Opere Role of the non-enzymatic metabolite of eicosapentaenoic acid, 5-epi-5-F3t-isoprostane in the regulation of [(3)H]D-aspartate release in isolated bovine retina Neurochem. Res 39 12 2014 2360 2369
40. V. Saraswathi, L. Gao, J.D. Morrow, A. Chait, K.D. Niswender, and A.H. Hasty Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice J. Nutr 137 2007 1776 1782
41. C. Gladine, J.W. Newman, T. Durand, T.L. Pedersen, J.-M. Galano, C. Demougeot, and et al. Lipid profiling following intake of the omega 3 fatty acid DHA identifies the peroxidized metabolites F4-neuroprostanes as the best predictors of atherosclerosis prevention PloS One 9 2014 e89393 10.1371/journal.pone.0089393
42. C. De Felice, L. Ciccoli, S. Leoncini, C. Signorini, M. Rossi, L. Vannuccini, and et al. Systemic oxidative stress in classic Rett syndrome Free Radic. Biol. Med 47 2009 440 448 10.1016/j.freeradbiomed.2009.05.016
43. C. De Felice, F. Della Ragione, C. Signorini, S. Leoncini, A. Pecorelli, L. Ciccoli, and et al. Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome Neurobiol. Dis 68 2014 66 77 10.1016/j.nbd.2014.04.006
44. E. Grillo, C. Lo Rizzo, L. Bianciardi, V. Bizzarri, M. Baldassarri, O. Spiga, and et al. Revealing the complexity of a monogenic disease: rett syndrome exome sequencing PloS One 8 2013 e56599 10.1371/journal.pone.0056599
45. 4-neuroprostanes mediate neurological severity in Rett syndrome Clin. Chim. Acta Int. J. Clin. Chem 412 2011 1399 1406 10.1016/j.cca.2011.04.016
46. S. Maffei, C. De Felice, P. Cannarile, S. Leoncini, C. Signorini, A. Pecorelli, and et al. Effects of ω-3 PUFAs supplementation on myocardial function and oxidative stress markers in typical Rett syndrome Mediat. Inflamm 2014 2014 983178 10.1155/2014/983178
47. J. Roy, C. Oger, J. Thireau, J. Roussel, O. Mercier-Touzet, D. Faure, and et al. Non-enzymatic lipid mediators, neuroprostanes, exert the anti-arrhythmic properties of docosahexaenoic acid Free Radic. Biol. Med 2015 10.1016/j.freeradbiomed.2015.04.014
48. J.Y. Le Guennec, J.M. Galano, Oger, Camille, J. Thireau, J. Roy, V. Bultel-Poncé, A. Guy, T. Durand, Methods and pharmaceutical composition for the treatment and prevention of cardiac arrhythmias, PCT 4 December 2013-PCT/EP2013/07546, (n.d.). http://www.google.com/patents/WO2014086819A1?cl=en (accessed 09.03.15).
49. R. Solberg, M. Longini, F. Proietti, P. Vezzosi, O.D. Saugstad, and G. Buonocore Resuscitation with supplementary oxygen induces oxidative injury in the cerebral cortex Free Radic. Biol. Med 53 2012 1061 1067 10.1016/j.freeradbiomed.2012.07.022
50. K.O. Arneson, and L.J. Roberts Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans Methods Enzymol 433 2007 127 143 10.1016/S0076-6879(07)33007-3